In a previous paired analysis of 12 radical prostatectomy specimens from men who subsequently developed metastatic, castrate-resistant prostate cancer, truncal events included SPOP mutations, TMPRSS2:ETS gene rearrangements, and TP53 mutations, which were all demonstrated to varying degrees in both primary and LN samples in our cohort25. Here, TP53 is linked to prostate carcinoma.